A new study has demonstrated that a clinical tool developed by the University of Liverpool and The Walton Center can effectively predict whether the most common type of brain tumor—diffuse glioma—will progress or lead to symptoms. The tool uses advanced imaging and clinical data to assess tumor behavior, enabling doctors to determine which patients are likely to need treatment and which may safely avoid it. This helps reduce unnecessary interventions and supports more personalized care. The findings could significantly improve decision-making for both clinicians and patients, especially in cases where tumors are detected early and are not yet causing symptoms. By identifying high-risk tumors early, the tool may also help prioritize treatment and improve outcomes. Researchers say the system is now being integrated into clinical practice and could become a standard part of brain tumor management.